Chemical Structure (Sulindac 01)
Sulindac
Product Images NDC 54738-902
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sulindac (NDC 54738-902). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Richmond Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (150 mg Tablet Bottle Label)
This is a description of a medication called Sulindac, with instructions for storage at 20° to 25°C and a warning to store it in a tight, light-resistant container. The medication is distributed by Richmond Pharmaceuticals in Virginia and manufactured by Mutual Pharmaceutical in Pennsylvania, in the form of a tablet with the imprint MP 112. The rest of the text includes unclear and unreadable characters, thus it is not available for an accurate description.*
Principal Display Panel (200 mg Tablet Bottle Label)
This is a medication called Sulindac, available in tablet form with a strength of 200mg per tablet. It is prescribed to patients by medical professionals and should only be taken as instructed. The medication should be stored at a controlled room temperature, between 68°F to 77°F. It is distributed by Richmond Pharmaceuticals and dispensed in a tight, light-resistant container. Each tablet is marked with the inscription "MP 116". There is a note for pharmacists to dispense the medication without a medication guide.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
